× Key messages Background Findings Perspectives Expert commentary

Advanced Hybrid Closed-Loop in T1D

Key messages

  • The automated Advanced Hybrid Closed-Loop system was effective in reducing mean HbA1c even in a well-controlled population of patients with type 1 diabetes.
  • No safety or device related issues were found in this 90-day trial.